UChicago Medicine completes AbbVie Foundation Cancer Pavilion construction

UChicago renewed to host NRG Oncology Statistics and Data Management Center for NCI

The University of Chicago was awarded $66 million in renewal funding from NCI to support the NRG Oncology Statistics and Data Management Center, which provides expertise in biostatistics, data management, and operational support for national clinical trials.

June 12, 2026

Vol.52 No.23

In Brief

NCI selects UChicago Medicine as a lead site for clinical trials

The University of Chicago Medicine Comprehensive Cancer Center has been granted a six-year, $5 million grant from NCI.

June 12, 2026

Vol.52 No.23

Podcast The Directors

The Directors: Ruben Mesa and Kunle Odunsi on how immigration and diversity accelerate discovery
“This has always made our environment stronger, not weaker.”

At a time when federal immigration policies are becoming stricter, Kunle Odunsi, director of University of Chicago Medicine Comprehensive Cancer Center, reflected on the fact that cancer research is a highly international community.

November 07, 2025

Vol.51 No.41

By Jacquelyn Cobb and Paul Goldberg

Obituary

Harvey Golomb, past chair of UChicago’s Department of Medicine, dies at 82
Golomb was a translational scientist (before that term was in vogue)

It is with profound sadness that I announce the passing of our esteemed colleague and friend, Dr. Harvey Golomb. He died on Aug. 20.

Researchers develop nicotinamide N-methyl transferase inhibitor to block ovarian cancer tumor growth

A team led by researchers at the University of Chicago discovered how to block nicotinamide N-methyl transferase, an enzyme that is involved in the progression of high-grade serous ovarian cancer.

July 25, 2025

Vol.51 No.29

In Brief

UChicago receives $75M from AbbVie Foundation for construction of the cancer care and research pavilion

UChicago Medicine received a $75 million donation from the AbbVie Foundation, a nonprofit focused on advancing health equity, to help fund the construction of the new cancer care and research pavilion.

November 01, 2024

Vol.50 No.41

UChicago Medicine completes AbbVie Foundation Cancer Pavilion construction

YOU MAY BE INTERESTED IN

UChicago renewed to host NRG Oncology Statistics and Data Management Center for NCI

NCI selects UChicago Medicine as a lead site for clinical trials

The Directors: Ruben Mesa and Kunle Odunsi on how immigration and diversity accelerate discovery
“This has always made our environment stronger, not weaker.”

Harvey Golomb, past chair of UChicago’s Department of Medicine, dies at 82
Golomb was a translational scientist (before that term was in vogue)

Researchers develop nicotinamide N-methyl transferase inhibitor to block ovarian cancer tumor growth

UChicago receives $75M from AbbVie Foundation for construction of the cancer care and research pavilion

Renew today!

Subscriber content

Never miss an issue!

Login

UChicago Medicine completes AbbVie Foundation Cancer Pavilion construction

YOU MAY BE INTERESTED IN

UChicago renewed to host NRG Oncology Statistics and Data Management Center for NCI

NCI selects UChicago Medicine as a lead site for clinical trials

The Directors: Ruben Mesa and Kunle Odunsi on how immigration and diversity accelerate discovery“This has always made our environment stronger, not weaker.”

Harvey Golomb, past chair of UChicago’s Department of Medicine, dies at 82Golomb was a translational scientist (before that term was in vogue)

Researchers develop nicotinamide N-methyl transferase inhibitor to block ovarian cancer tumor growth

UChicago receives $75M from AbbVie Foundation for construction of the cancer care and research pavilion

Never miss an issue!

Login

The Directors: Ruben Mesa and Kunle Odunsi on how immigration and diversity accelerate discovery
“This has always made our environment stronger, not weaker.”

Harvey Golomb, past chair of UChicago’s Department of Medicine, dies at 82
Golomb was a translational scientist (before that term was in vogue)